Asmax Chewable Tablets 4mg | Antiasthmatic & COPD Preparations | Pharmaceuticals | Products

Asmax Chewable Tablets 4mg

Code:

DRPS0088A

Active Ingredient:

Montelukast sodium 4.16mg

Description:

Pink oval chewable tablet, engraved "MM" on one side and "MTC4" on other side

Regulatory Class:

P1S1S3
Prescription Drug

HK-64807

Indication
Indication
Use and Administration

Indication

Use and Administration

ASMAX is indicated in the treatment of asthma as add-on therapy in those 2 to 5 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting beta agonists provide inadequate clinical control of asthma.
ASMAX may also be an alternative treatment option to low-dose inhaled corticosteroids for 2 to 5 year old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids.
ASMAX is also indicated in the prophylaxis of asthma from 2 years of age and older in which the predominant component is exercise-induced bronchoconstriction.

This medicinal product is to be given to a child under adult supervision. The dosage for paediatric patients 2-5 years of age is one 4 mg chewable tablet daily to be taken in the evening. If taken in connection with food, ASMAX should be taken 1 hour before or 2 hours after food. No dosage adjustment within this age group is necessary. The ASMAX 4mg chewable tablet formulation is not recommended below 2 years of age.